Via Figino 6 6917 Barbengo |
T.: +41 91 985 63 11 |
F.: +41 91 985 63 25 |
http://www.cerbios.ch |
info@cerbios.ch |
https://www.linkedin.com/company/307119 |
https://plus.google.com/+cerbios |
-
Main activities Licensing-Out ● Co-development ● Drug Substance CMO ● Other CMO Activities ● -
Drug stages Pre-clinical ● Phase I - Phase III ● Registration ● Market ● Generic Plus (505B2) ● Generic ● Life cycle management ● -
Therapeutic areas Cancer supportive therapy ● CNS ● Dermatology ● Gastrointestinal ● Oncology ● Ophtalmology ● Pain ● Respiratory ● Other ● -
Markets CH ● EU Top 5 ● Rest of Europe ● USA and Canada ● LATAM ● MENA ● BRICS ● ASEAN ● Africa ● Australia ● Brazil ● China ● India ● Japan ● Korea ● Other ● -
Drug product forms Oral (solid) ● Spray ● Topical ● -
Drug substance type APIs (1-10kgs/batch) ● APIs (20-200kgs/batch) ● HPAI 10-100g/batch ● HPAI 0.2-5kgs/batch ● HPAI 6-20kgs/batch ● HPAI Cat. 3 safebridge ● Cytotoxics ● HPAI Cat. 4 safebridge ● -
Other activities (non pharma) Feed Additives ● Medical Food ● Pre-formulation ● -
Other CMO activities Co-development ● Contract Micronization ○ Micronization ● Pre-formulation ● Spray-Drying ● Other ●
Linkedin